plerixafor has been researched along with Bucket Handle Tears in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, L; Chen, W; Chen, X; Fang, Z; Heng, BC; Ji, J; Ouyang, HW; Shen, W; Yin, Z; Zhang, W; Zhu, T | 1 |
| Chen, Y; Guo, J; Ho, KW; Li, G; Lin, S; Lu, Y; Pan, X; Suen, CW; Sun, Y; Zha, Z; Zhang, J | 1 |
2 other study(ies) available for plerixafor and Bucket Handle Tears
| Article | Year |
|---|---|
Intra-articular injection of human meniscus stem/progenitor cells promotes meniscus regeneration and ameliorates osteoarthritis through stromal cell-derived factor-1/CXCR4-mediated homing.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Benzylamines; Cartilage, Articular; Chemokine CXCL12; Collagen Type I; Collagen Type II; Collagen Type X; Cyclams; Gene Expression; Heterocyclic Compounds; Humans; Injections, Intra-Articular; Male; Menisci, Tibial; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Osteoarthritis; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Regeneration; Signal Transduction; Tibial Meniscus Injuries; Transplantation, Heterologous | 2014 |
Attenuation of subchondral bone abnormal changes in osteoarthritis by inhibition of SDF-1 signaling.
Topics: Aged; Animals; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Benzylamines; Bone and Bones; Cell Differentiation; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Knee Joint; Male; Menisci, Tibial; Mesenchymal Stem Cells; Middle Aged; Osteoarthritis, Knee; Osteogenesis; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Tibial Meniscus Injuries; X-Ray Microtomography | 2017 |